XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (28,171) $ (14,161)
Adjustments to reconcile net loss to net cash used in operations:    
Depreciation and amortization 4,104 4,009
Stock-based compensation expense 3,492 3,513
Provision for excess and obsolete inventory 1,247 1,627
Deferred income taxes 65 (2,136)
Change in fair value of contingent consideration (340) (4,440)
China dissolution 1,921 0
Non-cash interest income 0 (49)
Other non-cash items 185 407
Unrealized foreign exchange loss on cash and cash equivalents (3) (118)
Changes in operating asset and liability accounts:    
Accounts receivable 2,738 (4,528)
Inventory (16,324) (279)
Prepaid expenses and other assets (165) 85
Accounts payable and accrued expenses 2,565 (236)
Deferred revenue 11,619 381
Net cash used in operating activities (17,067) (15,925)
Cash flows from investing activities:    
Purchase of property, plant and equipment (970) (710)
Cash paid for acquisition, net of cash acquired 0 (11,479)
Proceeds from the maturity of marketable securities 0 5,189
Change in other assets (194) (56)
Net cash used in investing activities (1,164) (7,056)
Cash flows from financing activities:    
Repurchase of treasury stock 0 (46)
Repayment of debt (56) (30)
Proceeds from exercise of employee stock options and ESPP 127 125
Net cash provided by financing activities 71 49
Effect of exchange rate changes on cash 25 (51)
Net decrease in cash, cash equivalents and restricted cash (18,135) (22,983)
Cash, cash equivalents and restricted cash at beginning of period 49,486 75,539
Cash, cash equivalents and restricted cash at end of period 31,351 52,556
Supplemental schedule of cash flow information:    
Cash paid for income taxes, net of refunds 280 445
Non-cash investing and financing activities    
Issuance of common stock in connection with the purchase of Neeltran, Inc. 0 4,387
Issuance of common stock to settle liabilities $ 476 $ 2,643